X

Pushing competition and affordability with biosimilars

By: Michael Lim, PharmD Candidate c/o 2020 - In an era of widespread pharmaceutical innovation, the rise of biological products…

eMAR

Presentation and management of nivolumab (Opdivo®)-induced pneumonitis

By: Shireen Farzadeh, PharmD Candidate c/o 2019 - Nivolumab (Opdivo®) is a monoclonal antibody that blocks programmed death receptor-1 (PD-1).…

eMAR

Ibalizumab-uiyk (Trogarzo®): a newly FDA approved medication to treat multidrug resistant HIV-1 infection

By: Karen Chen, PharmD Candidate c/o 2019 - Ibalizumab-uiyk (Trogarzo®) is specifically indicated for the treatment of human immunodeficiency virus…

eMAR

Understanding treatment options for chronic pain management in geriatric populations

By: Alex Chu & Joseph Eskandrous (PharmD Candidates c/o 2019) - The geriatric population grows older with each passing day…

eMAR

An analysis of collaborative drug therapy management and its impact in New York State

By: Shireen Farzadeh, PharmD Candidate c/o 2019 - Collaborative Drug Therapy Management (CDTM) began as a three year demonstration project…

eMAR

Integral role of pharmacists in patient care and the interdisciplinary healthcare team

By: Shivani Shah, PharmD Candidate c/o 2021 - Pharmacists are the primary drug experts in the medical field. Medication reconciliation,…

eMAR

Assessing the current treatment recommendations for Graves’ disease

By: Natalie Rodriguez, PharmD Candidate 2019 Philadelphia College of Pharmacy, University of the Sciences  and Stacey Gorski, Assistant Professor of…

eMAR

Summer of adherence

By: Katharine Russo, PharmD Candidate c/o 2021 - Flight tickets, check. Passports, check. Luggage, check.   Month supply of Metformin, uh…

eMAR

Acetaminophen toxicity and n-acetylcysteine

By: Kathleen Horan, PharmD Candidate c/o 2020 - During my institutional Introductory Pharmacy Practice Experiential (IPPE) rotation in the emergency…

eMAR

Digital sensors in drugs and how they will impact pharmacotherapy

By: Jonathan Mercado, PharmD Candidate c/o 2019 - In November of 2017, the FDA approved the first drug to contain…

eMAR